EP on EP Episode 58 - AFib Ablation in CHF Patients-EP on EP Episode 58

EP on EP Episode 58_ AFib Ablation in CHF Patients

Video Transcription

Video Summary

In this video transcript, Dr. Nasir Maroosh and Dr. Douglas Packer discuss their respective trials on ablation for patients with atrial fibrillation (AFib) and heart failure. Dr. Maroosh discusses the findings of the CASLA-F trial, which showed that ablation significantly reduced the composite endpoint of mortality and hospitalization for heart failure in patients with AFib and left ventricular dysfunction. He also emphasizes the importance of reducing AFib burden in improving outcomes. Dr. Packer presents the key observations from the CABANA trial, which found a substantial reduction in mortality and heart failure hospitalization in AFib patients with heart failure. The discussion highlights the benefit of ablation in improving quality of life, reducing recurrence, and achieving normal sinus rhythm. Overall, the experts suggest considering ablation earlier in patients with mild heart failure and symptomatic AFib.

Keywords

ablation

atrial fibrillation

heart failure

CASLA-F trial

CABANA trial